Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?

被引：4
|
作者：
Oh, Joo Hyun [1 ]
Sinn, Dong Hyun [2 ,3 ]
机构：
[1] Eulji Univ, Nowon Eulji Med Ctr, Dept Med, Sch Med, Daejeon, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2023年 / 29卷 / 02期
关键词：
Hepatitis B; chronic; Biopsy; Fibrosis; CORE-RELATED ANTIGEN; MANAGEMENT; GUIDELINES; INFECTION;
D O I：
10.3350/cmh.2023.0054
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：367 / 370
页数：4
相关论文
共 50 条
  • [1] Correspondence on Letter regarding "Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?"
    Oh, Joo Hyun
    Sinn, Dong Hyun
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (03) : 820 - +
  • [2] Letter regarding "Is liver biopsy essential to identi- fying the immune tolerant phase of chronic hepatitis B?"
    Emiroglu, Halil Haldun
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (03)
  • [3] Definition and Management of the Immune Tolerance Phase in Chronic Hepatitis B
    Hong, Young Mi
    Yoon, Ki Tae
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2022, 79 (04) : 156 - 160
  • [4] Noninvasive diagnosis model for predicting significant liver inflammation in patients with chronic hepatitis B in the immune-tolerant phase
    Chen, Shanshan
    Huang, Lu
    Chu, Yili
    Lian, Jiangshan
    Shao, Hui
    Wang, Tingting
    Zou, Xuehan
    Huang, Haijun
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [5] Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
    Yip, Terry Cheuk-Fung
    Wong, Grace Lai-Hung
    Wong, Vincent Wai-Sun
    CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (02) : 273 - 277
  • [6] Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks
    Kennedy, Patrick T. F.
    Litwin, Samuel
    Dolman, Grace E.
    Bertoletti, Antonio
    Mason, William S.
    VIRUSES-BASEL, 2017, 9 (05):
  • [7] Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B
    Lee, Hye Won
    Chon, Young Eun
    Kim, Beom Kyung
    Yip, Terry Cheuk-Fung
    Tse, Yee-Kit
    Wong, Grace Lai-Hung
    Wong, Vincent Wai-Sun
    Chan, Henry Lik-Yuen
    Ahn, Sang Hoon
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 84 : 68 - 73
  • [8] Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase
    Lee, Han Ah
    Lee, Hyun Woong
    Kim, In Hee
    Park, Soo Young
    Sinn, Dong Hyun
    Yu, Jung Hwan
    Seo, Yeon Seok
    Um, Soon Ho
    Lee, Jung Il
    Lee, Kwan Sik
    Lee, Chang Hun
    Tak, Won Young
    Kweon, Young Oh
    Kang, Wonseok
    Paik, Yong-Han
    Lee, Jin-Woo
    Suh, Sang Jun
    Jung, Young Kul
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Yim, Hyung Joon
    Kim, Seung Up
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (01) : 196 - 204
  • [9] Risk of hepatocellular carcinoma among chronic hepatitis B patients presumed in immune tolerant phase
    Sinn, Dong Hyun
    Seong, Gyeol
    Kang, Wonseok
    Gwak, Geum-Youn
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    Paik, Yong-Han
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 138 - 138
  • [10] Serum HBsAg and HBeAg levels are associated with liver pathological stages in the immune clearance phase of hepatitis B virus chronic infection
    Zeng, Da-Wu
    Liu, Yu-Rui
    Dong, Jing
    Zhu, Yue-Yong
    Li, You-Bing
    Chen, Jing
    Zheng, Qi
    Jiang, Jia-Ji
    MOLECULAR MEDICINE REPORTS, 2015, 11 (05) : 3465 - 3472
12345